Global Hip Dysplasia Registry
Recruiting
Observational Study
Hip Dislocation, Congenital
Hip Dysplasia, Congenital, Nonsyndromic
Congenital Dysplasia of the Hip
Congenital Hip Dislocation
Congenital Hip Displacement
Congenital Hip Dysplasia
Dislocation of Hip, Congenital
Dislocation, Congenital Hip
Displacement, Congenital Hip
Dysplasia, Congenital Hip
Hip Displacement, Congenital
Hip, Dislocation Of, Congenital
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 1 Minute – 10
- Sex
- Any
- Study type
- Observational
- Participants needed
- 5,000 (estimated)
- Sponsor
- University of British Columbia · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Developmental dysplasia of the hip (DDH) is the most common hip condition affecting infants and children. DDH represents a spectrum of issues affecting the hip joint - a "ball-and-socket" joint. When the femoral head (the "ball) is seated properly in the acetabulum (the "socket"), the hip is stable and can develop normally. However, when the femoral head is not well-seated, the hip can become unst…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Between the ages of 0 and 10 years at time of initial diagnosis
* Referred for DDH screening due to specific risk factors OR diagnosed with DDH
* Diagnosis confirmed with appropriate ultrasonographic or radiographic imaging
Exclusion Criteria:
* Known or suspected neuromuscu…
Contacts